Peginterferon alfa-2a Approval Information - Licensing Action

Proper name: Peginterferon alfa-2a
Tradename: PEGASYS
Manufacturer: Hoffman-La Roche, Inc, Nutley, NJ, License #0136
Indication for Use: Combination therapy with Ribavirin, USP (Copegus), for the treatment of chronic hepatitis C virus infection
Approval Date: 12/3/2002
Type of submission: Biologics license application supplement


Label (PDF)

Page Last Updated: 05/16/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English